Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism.

Metadatas

Date

2011

type
Language
Identifiers
Relations

This document is linked to :
info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pone.0014665

This document is linked to :
info:eu-repo/semantics/altIdentifier/pmid/21326871

This document is linked to :
info:eu-repo/semantics/altIdentifier/eissn/1932-6203

This document is linked to :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_E36D61042E0B8

Licenses

info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer



Similar subjects En

Angiogenesis

Cite this document

S. Garrido-Urbani et al., « Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism. », Serveur académique Lausannois, ID : 10.1371/journal.pone.0014665


Metrics


Share / Export

Abstract 0

Reactive oxygen species, ROS, are regulators of endothelial cell migration, proliferation and survival, events critically involved in angiogenesis. Different isoforms of ROS-generating NOX enzymes are expressed in the vasculature and provide distinct signaling cues through differential localization and activation. We show that mice deficient in NOX1, but not NOX2 or NOX4, have impaired angiogenesis. NOX1 expression and activity is increased in primary mouse and human endothelial cells upon angiogenic stimulation. NOX1 silencing decreases endothelial cell migration and tube-like structure formation, through the inhibition of PPARα, a regulator of NF-κB. Administration of a novel NOX-specific inhibitor reduced angiogenesis and tumor growth in vivo in a PPARα dependent manner. In conclusion, vascular NOX1 is a critical mediator of angiogenesis and an attractive target for anti-angiogenic therapies.

document thumbnail

From the same authors

On the same subjects

Export in